Back to BlackRock, Inc. BlackRock, Inc.

RAPPRAPP
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in RAPPORT THERAPEUTICS INC

BlackRock, Inc. holds 2.7M shares of RAPP (RAPPORT THERAPEUTICS INC), worth $112.5M as of 2026-Q2. The position was increased (+7.7% shares). RAPP represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$112.5M

Current Shares

2.7M

Total Value Change

+$99.1M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+7.7%
$112.5M0.0%$41.67
32
2026-Q1
Increased
2.5M
+3.0%
$78.4M0.0%$27.85
31
2025-Q4
Increased
2.4M
+55.1%
$73.8M0.0%$30.64
42
2025-Q3
Increased
1.6M
+28.6%
$46.6M0.0%$27.97
37
2025-Q2
Increased
1.2M
+4.5%
$13.9M0.0%$11.43
29
2025-Q1
Increased
1.2M
+54.3%
$11.7M0.0%$10.05
39
2024-Q4
New
756,543
-
$13.4M0.0%$18.49
39

Other major holders of RAPP: FMR LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used